Cerebrooculofacioskeletal syndrome 2: genes and variants
Explore variant evidence for Cerebrooculofacioskeletal syndrome 2 across 2 analyzed proteins (ERCC2, ERCC5). Linked ClinVar records include 16 pathogenic or likely pathogenic variants, 42 variants of uncertain significance and 16 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Cerebrooculofacioskeletal syndrome 2
ERCC2: General transcription and DNA repair factor IIH helicase subunit XPD
Its XPD helicase activity unwinds damaged DNA during nucleotide-excision repair and also supports transcription initiation within TFIIH. Biallelic pathogenic variants cause xeroderma pigmentosum, trichothiodystrophy, or combined DNA-repair syndromes depending on the functional defect.
15 ClinVar pathogenic / likely pathogenic and 28 uncertain variants in ERCC2 have source records linked to Cerebrooculofacioskeletal syndrome 2. Association strength is not clinical gene validity.
ERCC5: DNA excision repair protein ERCC-5
It makes one of the two strand incisions required to remove bulky DNA lesions during nucleotide-excision repair and also supports repair-associated transcriptional responses. Biallelic pathogenic variants can cause xeroderma pigmentosum group G, Cockayne syndrome, or combined phenotypes.
1 ClinVar pathogenic / likely pathogenic and 30 uncertain variants in ERCC5 have source records linked to Cerebrooculofacioskeletal syndrome 2. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Cerebrooculofacioskeletal syndrome 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ERCC2 R658H | 658 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 R658C | 658 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 G47R | 47 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 S541R | 541 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 A725T | 725 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 A725P | 725 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 R511Q | 511 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 G675R | 675 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 R112H | 112 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 C259Y | 259 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 R601L | 601 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 R616W | 616 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 R666W | 666 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 T709P | 709 | Pathogenic / likely pathogenic (★★) | |
| ERCC5 A792V | 792 | I-domain | Pathogenic / likely pathogenic (★★) |
| ERCC2 C663R | 663 | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Cerebrooculofacioskeletal syndrome 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 100 out of 100
- MetaLR: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 99 out of 100
- CADD: 95 out of 100
- PolyPhen-2: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 90 out of 100
- SIFT: 90 out of 100
- SpliceAI: 71 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 41 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Xeroderma pigmentosum also has ClinVar records linked to ERCC2 variants; they fall partly in the same places as the Cerebrooculofacioskeletal syndrome 2 variants (15 pathogenic / likely pathogenic).
- Xeroderma pigmentosum also has ClinVar records linked to ERCC5 variants; they fall mostly in different places as the Cerebrooculofacioskeletal syndrome 2 variants (8 pathogenic / likely pathogenic).
Diseases related to Cerebrooculofacioskeletal syndrome 2
- Ovarian cancer, also linked to ERCC2 and ERCC5
- Xeroderma pigmentosum, also linked to ERCC2 and ERCC5
- Urinary bladder cancer, also linked to ERCC2
- Trichothiodystrophy 1, photosensitive, also linked to ERCC2
Frequently asked questions
Which genes have records linked to Cerebrooculofacioskeletal syndrome 2?
This view contains 2 analyzed proteins: ERCC2, ERCC5. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 16 pathogenic or likely pathogenic variants, 42 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 109 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center